These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12870431)

  • 41. siRNA for inflammatory diseases.
    Ponnappa BC
    Curr Opin Investig Drugs; 2009 May; 10(5):418-24. PubMed ID: 19431074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioreducible polymers for efficient gene and siRNA delivery.
    Jere D; Arote R; Jiang HL; Kim YK; Cho MH; Cho CS
    Biomed Mater; 2009 Apr; 4(2):025020. PubMed ID: 19349651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy.
    Hallaj-Nezhadi S; Lotfipour F; Dass CR
    Pharmazie; 2010 Dec; 65(12):855-9. PubMed ID: 21284252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanomedicinal delivery approaches for therapeutic siRNA.
    Keller M
    Int J Pharm; 2009 Sep; 379(2):210-1. PubMed ID: 19716034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.
    Prakash S; Malhotra M; Rengaswamy V
    Methods Mol Biol; 2010; 623():211-29. PubMed ID: 20217554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. siRNA delivery using peptide transduction domains.
    Eguchi A; Dowdy SF
    Trends Pharmacol Sci; 2009 Jul; 30(7):341-5. PubMed ID: 19545914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming.
    Saetrom P
    Bioinformatics; 2004 Nov; 20(17):3055-63. PubMed ID: 15201190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supramolecular assemblies in functional siRNA delivery: where do we stand?
    Aliabadi HM; Landry B; Sun C; Tang T; Uludağ H
    Biomaterials; 2012 Mar; 33(8):2546-69. PubMed ID: 22209641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of antisense oligonucleotides for gene functionalization and target validation.
    Bennett CF; Cowsert LM
    Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular therapy in support to radiotherapy.
    Dutreix M; Cosset JM; Sun JS
    Mutat Res; 2010; 704(1-3):182-9. PubMed ID: 20067843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. siRNA therapeutics in the treatment of diseases.
    Bakhtiyari S; Haghani K; Basati G; Karimfar MH
    Ther Deliv; 2013 Jan; 4(1):45-57. PubMed ID: 23323780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges for RNAi in vivo.
    Paroo Z; Corey DR
    Trends Biotechnol; 2004 Aug; 22(8):390-4. PubMed ID: 15283982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Mol Cancer Ther; 2007 Mar; 6(3):833-43. PubMed ID: 17363479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies for tumor-directed delivery of siRNA.
    Chowdhury EH
    Expert Opin Drug Deliv; 2011 Mar; 8(3):389-401. PubMed ID: 21314230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA and carbon nanotubes as medicine.
    Cheung W; Pontoriero F; Taratula O; Chen AM; He H
    Adv Drug Deliv Rev; 2010 Apr; 62(6):633-49. PubMed ID: 20338203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The zebrafish as a novel system for functional genomics and therapeutic development applications.
    Nasevicius A; Ekker SC
    Curr Opin Mol Ther; 2001 Jun; 3(3):224-8. PubMed ID: 11497344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. siRNA: novel therapeutics from functional genomics.
    Joshi BH; Pachchigar KP
    Biotechnol Genet Eng Rev; 2014 Oct; 30(1-2):1-30. PubMed ID: 25023460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis.
    Shi Q; Zhang XL; Dai KR; Benderdour M; Fernandes JC
    Expert Opin Biol Ther; 2011 Jan; 11(1):5-16. PubMed ID: 21058934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential.
    Larsson M; Huang WT; Liu DM; Losic D
    Cancer Treat Rev; 2017 Apr; 55():128-135. PubMed ID: 28363142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleic acid delivery for therapeutic applications.
    Gupta A; Andresen JL; Manan RS; Langer R
    Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.